Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice
Ronald Witteles(British Heart Foundation), Pablo García‐Pavía(Universidad Francisco de Vitoria), Claudio Rapezzi(Boston University), Sabahat Bokhari(Boston University), Thibaud Damy(Amyloidosis Foundation), Rodney H. Falk(Boston University), Laura Obici(Amyloidosis Foundation), Perry Elliott(UCL Australia), Мариана Господинова(Ministry of Interior), Nowell M. Fine(Union Hospital)
Cited by 345
Related Papers
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k